These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 889573)

  • 1. Biologically active macromolecular forms of oxytocin. [8-Lysine]oxytocin as a suitable ligand.
    Snell CR; Smyth DG
    Biochem J; 1977 Jul; 165(1):43-7. PubMed ID: 889573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined high oxytocic with negligible antidiuretic and pressor activities in multisubstituted oxytocins.
    Stahl GL; Walter R
    J Med Chem; 1977 Apr; 20(4):492-5. PubMed ID: 850233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescent, photoaffinity, and biotinyl analogs of oxytocin.
    Buku A; Yamin N; Gazis D
    Peptides; 1988; 9(4):783-6. PubMed ID: 3226954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A ureido group containing analogue of oxytocin comprising eight amino acid residues.
    Bodanszky M; Fagan DT; Walter R; Smith CW
    J Med Chem; 1978 Mar; 21(3):306-8. PubMed ID: 628007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of pituitary hormone analogs for their inhibitory properties and resistance to carboxamidopeptidases: (9-L-proline)oxytocin, (9-L-glutamic acid)oxytocin, and (8-L-lysine,9-glycine methylamide)oxytocin.
    Grzonka Z; Glass JD; Schwartz IL; Walter R
    J Med Chem; 1974 Dec; 17(12):1294-8. PubMed ID: 4427327
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and some pharmacological properties of [4-threonine,7-sarcosine]oxytocin, a peptide with high oxytocic potency, and of [4-threonine,7-N-methylalanine]oxytocin.
    Grzonka Z; Lammek B; Gazis D; Schwartz IL
    J Med Chem; 1983 Dec; 26(12):1786-7. PubMed ID: 6685771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (1-beta-mercapto-beta,beta-diethylpropionic acid,4-leucine)-8-lysine-vasopressin and (1-beta-mercapto-beta,beta-diethylpropionic acid,4-leucine)oxytocin, compounds possessing antihormonal properties.
    Dyckes DF; Nestor JJ; Ferger MF; Du Vigneaud V; Chan WY
    J Med Chem; 1974 Sep; 17(9):969-72. PubMed ID: 4855467
    [No Abstract]   [Full Text] [Related]  

  • 8. Oxytocin and lysine-vasopressin with N5,N5-dialkylglutamine in the 4 position: effect of introducing sterically hindered groups into the hydrophilic cluster of neurohypophyseal hormones.
    Stahl GL; Smith CW; Walter R; Tsegenidis T; Stavropoulos G; Cordopatis P; Theodoropoulos D
    J Med Chem; 1980 Feb; 23(2):213-7. PubMed ID: 7359537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-oxytocin).
    Manning M; Lowbridge J; Sawyer WH; Haldar J
    J Med Chem; 1976 Mar; 19(3):376-80. PubMed ID: 943546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [1-Beta-mercapto-beta,beta-pentamethylenepropionic acid]oxytocin, a potent inhibitor of oxytocin.
    Nestor JJ; Ferger MF; du Vigneaud V
    J Med Chem; 1975 Mar; 18(3):284-7. PubMed ID: 1133819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of oxytocin analogues containing L-alpha-t-butylglycine [Gly(Bu t)] in positions 8 or 9.
    Fragiadaki M; Magafa V; Slaninová J; Cordopatis P
    Peptides; 2003 Sep; 24(9):1425-31. PubMed ID: 14706558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and some pharmacological properties of [4-threonine, 7-glycine]oxytocin, [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine, 7-glycine]oxytocin (hydroxy[Thr4, Gly7]oxytocin), and [7-Glycine]oxytocin, peptides with high oxytocic-antidiuretic selectivity.
    Lowbridge J; Manning M; Haldar J; Sawyer WH
    J Med Chem; 1977 Jan; 20(1):120-3. PubMed ID: 833810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and some pharmacological properties of [Glu(OMe)4]oxytocin and [Mpr1, Glu(OMe)4]oxytocin.
    Photaki I; Tzougraki C; Kotsira-Engonopoulos C
    Int J Pept Protein Res; 1979 Apr; 13(4):426-33. PubMed ID: 457336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of biologically active dicarba analogues of the peptide hormone oxytocin using ring-closing metathesis.
    Stymiest JL; Mitchell BF; Wong S; Vederas JC
    Org Lett; 2003 Jan; 5(1):47-9. PubMed ID: 12509887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction of a cis-prolyl mimic in position 7 of the peptide hormone oxytocin does not result in antagonistic activity.
    Wittelsberger A; Patiny L; Slaninova J; Barberis C; Mutter M
    J Med Chem; 2005 Oct; 48(21):6553-62. PubMed ID: 16220972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biofunctional evaluation of a hydrogen bond linking the ring and tail beta-turns of oxytocin.
    Roy J; Roy U; Gazis DC; Schwartz IL
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3309-13. PubMed ID: 291004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of changing the COOH-terminal amide group present in the hydrophilic cluster of oxytocin to dimethylamide.
    Ting YF; Smith CW; Stahl GL; Walter R; Cordopatis P; Theodoropoulos D
    J Med Chem; 1980 Jun; 23(6):693-5. PubMed ID: 7392037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonists of oxytocin featuring replacement with modified beta-mercaptopropionic acids at position 1.
    Flouret G; Majewski T; Balaspiri L; Brieher W; Mahan K; Chaloin O; Wilson L; Slaninová J
    J Pept Sci; 2002 Jul; 8(7):314-26. PubMed ID: 12148781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-phase synthesis of (4-threonine)-oxytocin. A more potent and specific oxytocic agent than oxytocin.
    Manning M; Coy E; Sawyer WH
    Biochemistry; 1970 Sep; 9(20):3925-30. PubMed ID: 5533681
    [No Abstract]   [Full Text] [Related]  

  • 20. Active-site studies of neurohypophyseal hormones: synthesis and pharmacological properties of [5-(N4,N4-dimethylasparagine)]oxytocin.
    Walter R; Stahl GL; Caplaneris T; Cordopatis P; Theodoropoulos D
    J Med Chem; 1979 Jul; 22(7):890-3. PubMed ID: 448689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.